Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Image: Tenacia will get sole rights to develop and commercialise some formulations of ganaxolone, including the present oral and intravenous (IV) dose formulations. Credit: Pexels från Pixabay.